Virtual Medicinal Product (VMP) - Rifaximin 550mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Rifaximin 550mg tablets Start Date 25-04-2012 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A07AA11
BNF Start Date End Date
Current BNF 05010700 Start Date 04-04-2022 End Date
Previous BNF 05010700 Start Date 25-09-2013 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
41955011000001108 09-06-2023
445522003 26-04-2012 08-06-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Rifaximin Based on Ingredient Substance 550 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 tablet
56 tablet 25923 Part VIIIA Category C
60 tablet
98 tablet